Aperçu du marché et point de vue des analystes :
Les prévisions du marché des ballons d'angioplastie peuvent aider les parties prenantes de ce marché à planifier leurs stratégies de croissance. Le rapport inclut les perspectives de croissance, ainsi que les tendances du marché des ballons d'angioplastie et leur impact prévisible au cours de la période de prévision.
Une angioplastie est une technique utilisée pour élargir les artères coronaires rétrécies ou ouvertes et rétablir le flux sanguin. Les soins fondés sur la valeur, axés sur la rentabilité et les résultats pour les patients, sont en train de transformer le secteur de la santé. Le marché des ballons d'angioplastie sera influencé par la capacité de ces dispositifs à fournir de meilleurs résultats pour les patients, des taux de revascularisation réduits et des coûts inférieurs par rapport aux autres traitements disponibles. Comparés aux méthodes chirurgicales conventionnelles, les ballons d'angioplastie constituent une méthode moins invasive de traitement des artères obstruées. Le besoin de ballons d'angioplastie augmente à mesure que les patients et les professionnels de la santé montrent une plus grande préférence pour les procédures moins invasives. La prévalence croissante des maladies cardiovasculaires et la préférence croissante pour les procédures mini-invasives contribuent à la taille croissante du marché des ballons d’angioplastie. Cependant, les complications associées à l'angioplastie entravent la croissance du marché.
Moteurs de croissance :
La prévalence croissante des maladies cardiovasculaires stimule le marché des ballons d'angioplastie
Selon l'Organisation mondiale de la santé ( OMS), les maladies cardiovasculaires constituent la première cause de morbidité et de mortalité dans le monde. Les maladies cardiovasculaires comprennent les maladies cérébrovasculaires, les maladies coronariennes et les cardiopathies rhumatismales. Les principaux facteurs liés au mode de vie à l’origine des maladies cardiovasculaires et des difficultés associées sont, entre autres, la consommation de tabac, une mauvaise alimentation et l’inactivité physique. Selon l'American Heart Association Inc., les décès liés aux maladies cardiovasculaires enregistrés en 2020 sont passés à 928 741 contre 874 613 en 2019. En 2020, les maladies coronariennes étaient la principale cause (41,2 %) des décès attribuables aux maladies cardiovasculaires aux États-Unis, viennent ensuite les accidents vasculaires cérébraux (17,3 %), l'hypertension artérielle (12,9 %), l'insuffisance cardiaque (9,2 %), les maladies des artères (2,6 %) et d'autres maladies cardiovasculaires (16,8 %). En outre, la Fédération mondiale du cœur prévoit plus de 23 millions de décès liés aux maladies cardiovasculaires par an d'ici 2030.
De plus, les facteurs de risque cardiovasculaire sont très répandus en Europe centrale et occidentale, en raison des habitudes tabagiques et des taux de consommation élevés d'alcool. , surtout chez les hommes. Plus de 4 millions d'Européens meurent chaque année de maladies cardiovasculaires, principalement dues à des maladies coronariennes et à des accidents vasculaires cérébraux. Le Moyen-Orient a également un taux de prévalence élevé de maladies cardiovasculaires, ce qui a accru le besoin de diverses interventions telles que l'éducation sanitaire, les conseils sur le mode de vie, le dépistage et le traitement dans cette région. Selon la Fédération mondiale du cœur, les maladies cardiovasculaires sont la principale cause de décès au Moyen-Orient et en Afrique du Nord, représentant plus d'un tiers de tous les décès, soit 1,4 million de personnes par an. Ainsi, la prévalence croissante des maladies cardiovasculaires propulse la croissance du marché des ballons d'angioplastie.
Les opérations d'angioplastie sont considérées par la plupart comme sûres, mais des cas de problèmes se développant pendant ou avec l'âge de l'opération ont été signalés. Un caillot sanguin, un rythme cardiaque irrégulier, des lésions d'un vaisseau sanguin ou d'une valvule cardiaque, un accident vasculaire cérébral, une réponse allergique au matériau du stent ou au stent à élution médicamenteuse, une resténose intra-stent ou un colmatage de l'intérieur du stent sont quelques-uns des risques impliqués dans l'angioplastie. opérations. Si certains de ces risques sont extrêmement dangereux, d’autres peuvent même être mortels. De plus, dans certaines circonstances, le patient peut ne pas disposer de suffisamment de temps pour subir une angioplastie. Cela se produit généralement en cas de crise cardiaque. Tous ces problèmes entravent la croissance du marché des ballons d'angioplastie.
Aperçus stratégiques
Segmentation et portée du rapport :
L'analyse du marché des ballons d'angioplastie a été réalisée en considérant les segments suivants : type, application et utilisateur final.
Analyse segmentaire :
Par type, le marché des ballons d'angioplastie est segmenté en ballons normaux, ballons à élution médicamenteuse, ballons coupants et ballons inciseurs. Le segment des ballons normaux détenait la plus grande part de marché en 2022. Cependant, le segment des ballons à élution médicamenteuse devrait enregistrer le TCAC le plus élevé au cours de la période 2022-2030.
Marché des ballons d'angioplastie, par type - 2022 et 2030
Par application, le marché des ballons d'angioplastie est divisé en périphériques et coronaires. Le segment coronarien détenait une part de marché des ballons d’angioplastie plus importante en 2022 et devrait enregistrer le TCAC le plus élevé au cours de la période 2022-2030 en raison de la prévalence croissante des maladies coronariennes, en particulier des maladies cardiaques. Selon la mise à jour de mars 2023 des Centers for Disease Control and Prevention (CDC), la maladie coronarienne est le type de maladie cardiaque le plus répandu, touchant environ 1 personne sur 20 âgée de 20 ans et plus. Cependant, le segment périphérique devrait enregistrer un TCAC plus élevé au cours de la période 2022-2030.
Le marché des ballons d'angioplastie, basé sur l'utilisateur final, est segmenté en hôpitaux, centres de chirurgie ambulatoire et laboratoires de cathétérisme. Le segment des hôpitaux détenait la plus grande part de marché des ballons d'angioplastie en 2022 et devrait enregistrer le TCAC le plus élevé au cours de la période 2022-2030.
Analyse régionale :
La portée géographique du rapport sur le marché des ballons d'angioplastie comprend Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient et Afrique, Amérique du Sud et centrale. L'Amérique du Nord détenait la plus grande part de marché en 2022. La croissance du marché en Amérique du Nord est tirée par le fardeau croissant d'une population vieillissante, le nombre croissant de lancements de produits et les activités de R&D visant à développer des ballons d'angioplastie avancés.
Paysage concurrentiel et entreprises clés :
Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, CR Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK et Terumo Medical Corporation font partie des sociétés de premier plan profilées sur le marché des ballons d'angioplastie. rapport. Ces entreprises se concentrent sur le développement de nouvelles technologies, la mise à niveau des produits existants et l'expansion de leur présence géographique pour répondre à la demande croissante des consommateurs du monde entier. Selon les communiqués de presse de l'entreprise, vous trouverez ci-dessous quelques développements clés récents :
•En mars 2023, aux États-Unis, SIS Medical AG a introduit le cathéter de dilatation OPN NC PTCA doté de la technologie TWIN-Wall. En offrant d'excellentes performances et sécurité ainsi que des taux de réussite là où d'autres ballons échouent, le produit élargit les possibilités thérapeutiques. Le cathéter OPN NC présente une conception à double paroi, qui offre une résistance à la pression très élevée avec une pression d'éclatement nominale de 35 atm avec une conformité considérablement faible. En septembre 2022, la FDA a accordé à Advanced NanoTherapies une désignation de dispositif révolutionnaire ( BDD) pour son SirPlux Duo Drug-Coated Balloon (DCB) destiné au traitement des maladies coronariennes. SirPlux Duo DCB délivre une libération à faible dose et à long terme des deux composés pour inhiber la croissance cellulaire, ce qui entraîne une puissance maximale dépassant tout autre DCB ou stent à élution médicamenteuse. En janvier 2022, le cathéter PTCA Scoreflex NC Scoring a reçu l'approbation préalable à la commercialisation. (PMA) de la Food and Drug Administration (FDA) des États-Unis. Le Scoreflex NC est un cathéter PTCA inscriptible indiqué pour la partie sténosée de novo d'une artère coronaire et la resténose intra-stent dans les artères coronaires chez les patients présentant une ischémie coronarienne dans le but d'améliorer la perfusion myocardique.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
An angioplasty is a technique used to open widen up narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, lower reduced rates of revascularization, and lower costs as compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries. The need for angioplasty balloons is rising as patients and medical professionals show a greater preference for less invasive procedures.
The factors that are driving the growth of the market are the rising prevalence of cardiovascular diseases and rising increasing preference for minimally invasive procedures.
The angioplasty balloonss market majorly consists of players such as Abbott, Boston Scientific Corporation, Cardinal Health, Cook Medical, C. R. Bard Inc, ENDOCOR GmbH, Medtronic, Spectranetics, BIOTRONIK, and Terumo Medical Corporation among others.
US holds the largest market share in angioplasty balloonss market due to the increasing cases of heart disease. According to the American Heart Association, due to cardiovascular diseases, one person dies every 34 seconds in the US. In 2020, ~697,000 people in the US died from heart disease, i.e., one in every five deaths.
The angioplasty balloonss market, based on type, is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022–2030.
The angioplasty balloonss market, based on application, is is bifurcated into peripheral and coronary. The coronary segment held a larger angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
Asia Pacific is expected to be the fastest-growing region in the angioplasty balloonss market. The region occupies a significant position in the global angioplasty balloons market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are the increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.
The angioplasty balloonss market, based on end user, is segmented into hospitals, ambulatory surgery centers, and cath labs. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.
The List of Companies - Angioplasty Balloons Market
- Abbott
- Boston Scientific Corporation
- Cardinal Health
- Cook Medical
- C. R. Bard Inc
- ENDOCOR GmbH
- Medtronic
- Spectranetics
- BIOTRONIK
- Terumo Medical Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)